COMPANY
Actym Therapeutics
Timeline
- Trial start 1: A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06336148 | A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors | 1 | Terminated | Jun 5, 2024 | Aug 28, 2025 (actual) |